RecruitingNCT06525688

New Biomarkers and Therapeutic Targets in Osteoporosis Via Omics Technologies

Identification of New Biomarkers and Potential Therapeutic Targets in Clinical Osteoporosis Using Omics Technologies

Sponsor

National and Kapodistrian University of Athens

Enrollment

60 participants

Start Date

Jul 3, 2024

Study Type

OBSERVATIONAL

Conditions

Osteoporosis, Postmenopausal Osteoporosis Fracture Osteoporosis, Severe

Summary

This study aims to discover novel biomarkers and therapeutic targets for osteoporosis through the use of advanced omics technologies, including proteomics and metabolomics. By analyzing bone and plasma samples from patients with osteoporosis, the research seeks to understand the underlying mechanisms of the disease and identify potential diagnostic and therapeutic biomarkers.

Eligibility

Sex: FEMALE

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Bone, Serum and Plasma sample for people with osteoporosis fracture, osteoporosis, postmenopausal, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBone, Serum and Plasma sample

Intervention: Bone samples will be collected during surgery from the femoral neck (which is typically removed and discarded in these operations) and fasting morning blood samples.